APA (7th ed.) Citation

ERA, P., M, D., O, V., EFM, P., DE, I., MED, C., . . . AG, D. (2024). Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: A contemporary, nationwide, population-based study in the Netherlands. Blood cancer journal, 14(1), 3. https://doi.org/10.1038/s41408-023-00970-z

Chicago Style (17th ed.) Citation

ERA, Pennings, Durmaz M, Visser O, Posthuma EFM, Issa DE, Chamuleau MED, Lugtenburg PJ, Kersten MJ, and Dinmohamed AG. "Treatment and Outcomes for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma: A Contemporary, Nationwide, Population-based Study in the Netherlands." Blood Cancer Journal 14, no. 1 (2024): 3. https://doi.org/10.1038/s41408-023-00970-z.

MLA (9th ed.) Citation

ERA, Pennings, et al. "Treatment and Outcomes for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma: A Contemporary, Nationwide, Population-based Study in the Netherlands." Blood Cancer Journal, vol. 14, no. 1, 2024, p. 3, https://doi.org/10.1038/s41408-023-00970-z.